CH532021A - Verfahren zur Herstellung von therapeutisch wirksamen Hydroxycyclohexancarbonsäureestern - Google Patents

Verfahren zur Herstellung von therapeutisch wirksamen Hydroxycyclohexancarbonsäureestern

Info

Publication number
CH532021A
CH532021A CH757171A CH757171A CH532021A CH 532021 A CH532021 A CH 532021A CH 757171 A CH757171 A CH 757171A CH 757171 A CH757171 A CH 757171A CH 532021 A CH532021 A CH 532021A
Authority
CH
Switzerland
Prior art keywords
preparation
acid esters
therapeutically active
hydroxycyclohexanecarboxylic acid
hydroxycyclohexanecarboxylic
Prior art date
Application number
CH757171A
Other languages
English (en)
Inventor
Luigi Dr Turbanti
Original Assignee
Guidotti & C Spa Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guidotti & C Spa Labor filed Critical Guidotti & C Spa Labor
Priority claimed from CH562367A external-priority patent/CH522592A/de
Publication of CH532021A publication Critical patent/CH532021A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/02Saturated compounds containing hydroxy or O-metal groups
    • C07C62/04Saturated compounds containing hydroxy or O-metal groups with a six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CH757171A 1966-04-29 1967-04-20 Verfahren zur Herstellung von therapeutisch wirksamen Hydroxycyclohexancarbonsäureestern CH532021A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT991366 1966-04-29
CH562367A CH522592A (de) 1966-04-29 1967-04-20 Verfahren zur Herstellung von therapeutisch wirksamen Hydroxycyclohexancarbonsäureestern

Publications (1)

Publication Number Publication Date
CH532021A true CH532021A (de) 1972-12-31

Family

ID=25698102

Family Applications (3)

Application Number Title Priority Date Filing Date
CH757071A CH513796A (de) 1966-04-29 1967-04-20 Verfahren zur Herstellung einer therapeutisch wirksamen Hydroxycyclohexancarbonsäure
CH63072A CH527153A (de) 1966-04-29 1967-04-20 Verfahren zur Herstellung von therapeutisch wirksamen Hydroxycyclohexancarbonsäuren
CH757171A CH532021A (de) 1966-04-29 1967-04-20 Verfahren zur Herstellung von therapeutisch wirksamen Hydroxycyclohexancarbonsäureestern

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CH757071A CH513796A (de) 1966-04-29 1967-04-20 Verfahren zur Herstellung einer therapeutisch wirksamen Hydroxycyclohexancarbonsäure
CH63072A CH527153A (de) 1966-04-29 1967-04-20 Verfahren zur Herstellung von therapeutisch wirksamen Hydroxycyclohexancarbonsäuren

Country Status (1)

Country Link
CH (3) CH513796A (de)

Also Published As

Publication number Publication date
CH527153A (de) 1972-08-31
CH513796A (de) 1971-10-15

Similar Documents

Publication Publication Date Title
CH500228A (de) Verfahren zur Herstellung von Phosphorsäureestern
CH479590A (de) Verfahren zur Herstellung von Benzimidazolylcarbaminsäureestern
CH491113A (de) Verfahren zur Herstellung von Polycarbonsäureestern
CH495994A (de) Verfahren zur Herstellung von Polycarbonsäureestern
CH508580A (de) Verfahren zur Herstellung von Cyclopropancarbonsäureestern
CH433385A (de) Verfahren zur Herstellung von Cumaranyl-N-methyl-carbaminsäureestern
AT271455B (de) Verfahren zur Herstellung von neuen substituierten Phenylaminophenylessigsäureestern
CH494205A (de) Verfahren zur Herstellung von Carbonsäure-2-aryloxyäthylestern
CH489478A (de) Verfahren zur Herstellung von Indanyl-N-methylcarbaminsäureestern
AT243234B (de) Verfahren zur Herstellung von Lösungen von Peroxydikohlensäureestern
CH484038A (de) Verfahren zur Herstellung von Mono- oder Polyacetessigsäureestern
AT272292B (de) Verfahren zur Herstellung von Carbonsäureglycidylestern
CH480298A (de) Verfahren zur Herstellung von d-Pantothenolestern
CH500936A (de) Verfahren zur Herstellung von Carbonsäureestern
AT277960B (de) Verfahren zur Herstellung von N-Hydroxyimidothiocarbonsäureestern
CH495381A (de) Verfahren zur Herstellung von Thionothiolphosphor-, -phosphon- oder -phosphin-säureestern
CH513104A (de) Verfahren zur Herstellung von Diameisensäureestern
CH481933A (de) Verfahren zur Herstellung von 4-Methyl-oxazol-5-carbonsäureestern
CH491961A (de) Verfahren zur Herstellung von Thio-Phosphor- oder Thio-Phosphonsäureestern
CH463485A (de) Verfahren zur Herstellung von Phenyl-benzolsulfon-säureestern
CH499483A (de) Verfahren zur Herstellung von Phenoxyphthalsäureester
CH495940A (de) Verfahren zur Herstellung von Carbonsäureestern
CH532021A (de) Verfahren zur Herstellung von therapeutisch wirksamen Hydroxycyclohexancarbonsäureestern
AT286311B (de) Verfahren zur Herstellung von 2-Benzimidazol-carbaminsäureestern
AT274763B (de) Verfahren zur Herstellung von neuen Dihydrochloriden von Farnesylsäureestern

Legal Events

Date Code Title Description
PL Patent ceased